Page last updated: 2024-10-24

butalbital and Liver Cirrhosis

butalbital has been researched along with Liver Cirrhosis in 1 studies

butalbital: management of butalbital withdrawal can be simplified by using a phenobarbital-loading protocol; RN given refers to parent cpd
butalbital : A member of the class of barbiturates that is barbituric acid in which the hydrogens at position 5 are substituted by an allyl group and an isobutyl group. Frequently combined with other medicines, such as aspirin, paracetamol and codeine, it is used for treatment of pain and headache.

Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Migneco, G1
Mascarella, A1
Tripi, S1
La Cascia, C1
Navetta, A1

Other Studies

1 other study available for butalbital and Liver Cirrhosis

ArticleYear
[Cytolytic episodes during cirrhosis].
    La Clinica terapeutica, 1986, Jul-31, Volume: 118, Issue:2

    Topics: Antipyrine; Anxiety Disorders; Barbiturates; Caffeine; Cholestasis; Drug Therapy, Combination; Femal

1986